Improvement of muscle strength in a mouse model for congenital myopathy treated with HDAC and DNA methyltransferase inhibitors
Sign Up to like & getrecommendations! Published in 2022 at "eLife"
DOI: 10.7554/elife.73718
Abstract: To date there are no therapies for patients with congenital myopathies, muscle disorders causing poor quality of life of affected individuals. In approximately 30% of the cases, patients with congenital myopathies carry either dominant or… read more here.
Keywords: ryr1 mutations; muscle; mouse model; muscle strength ... See more keywords